H3F3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.740000E-01
Normal-vs-Stage2
7.296600E-01
Normal-vs-Stage3
7.663200E-01
Normal-vs-Stage4
8.763600E-01
Stage1-vs-Stage2
3.583000E-01
Stage1-vs-Stage3
4.886000E-01
Stage1-vs-Stage4
4.693600E-01
Stage2-vs-Stage3
6.325000E-01
Stage2-vs-Stage4
8.685200E-01
Stage3-vs-Stage4
6.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.104400E-01
Normal-vs-AfricanAmerican
8.343400E-01
Normal-vs-Asian
5.533600E-01
Caucasian-vs-AfricanAmerican
4.387600E-01
Caucasian-vs-Asian
6.509800E-01
AfricanAmerican-vs-Asian
2.986400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.964800E-01
Normal-vs-Female
7.778000E-01
Male-vs-Female
6.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.534200E-01
Normal-vs-Age(41-60Yrs)
8.711800E-01
Normal-vs-Age(61-80Yrs)
5.754000E-01
Normal-vs-Age(81-100Yrs)
3.175800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.866400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.539200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.725200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.101740E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.523600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.863200E-01
Normal-vs-Daily Drinker
7.948400E-01
Normal-vs-Weekly Drinker
3.033200E-01
Normal-vs-Occasional Drinker
9.132800E-01
Normal-vs-Social Drinker
7.507600E-01
Non Drinker-vs-Daily Drinker
8.824200E-01
Non Drinker-vs-Weekly Drinker
3.473600E-01
Non Drinker-vs-Occasional Drinker
7.145600E-01
Non Drinker-vs-Social Drinker
8.985800E-01
Daily Drinker-vs-Weekly Drinker
2.151000E-01
Daily Drinker-vs-Occasional Drinker
7.992400E-01
Daily Drinker-vs-Social Drinker
9.935200E-01
Weekly Drinker-vs-Occasional Drinker
1.760400E-01
Weekly Drinker-vs-Social Drinker
1.960440E-01
Occasional Drinker-vs-Social Drinker
7.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.259800E-02
Normal-vs-Grade 2
3.430000E-02
Normal-vs-Grade 3
1.003770E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.924970E-01
Grade 1-vs-Grade 3
2.229800E-02
Grade 1-vs-Grade 4
5.259800E-02
Grade 2-vs-Grade 3
2.235000E-01
Grade 2-vs-Grade 4
3.430000E-02
Grade 3-vs-Grade 4
1.003770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.977600E-01
Normal-vs-NonDiabetic
8.442200E-01
Diabetic-vs-NonDiabetic
1.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.529200E-01
Normal-vs-NoPancreatitis
6.915800E-01
Pancreatitis-vs-NoPancreatitis
3.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.692200E-01
Normal-vs-N1
6.965400E-01
N0-vs-N1
5.297800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.541400E-01
Normal-vs-TP53-NonMutant
3.515400E-01
TP53-Mutant-vs-TP53-NonMutant
6.056600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
